Related Experiment Video
Updated: Jun 20, 2025
07:53
A Fluorogenic Peptide Cleavage Assay to Screen for Proteolytic Activity: Applications for coronavirus spike protein activation
Published on: January 9, 2019
33.2K
3-chymotrypsin-like protease in SARS-CoV-2
Kenana Al Adem1, Juliana C Ferreira1, Adrian J Villanueva1
1Science Division, New York University Abu Dhabi, PO Box 129188, Abu Dhabi, United Arab Emirates.
Bioscience Reports
|July 22, 2024
Summary
Targeting the main protease (3CLpro) of SARS-CoV-2 is crucial for developing effective COVID-19 antiviral strategies. Inhibitors of 3CLpro block viral replication by preventing essential polyprotein cleavage.
Area of Science:
- Virology
- Drug Discovery
- Structural Biology
Background:
- Coronaviruses, including SARS-CoV-2, pose a significant global health threat.
- Severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) causes the COVID-19 pandemic.
- Effective antiviral therapies are urgently needed to combat widespread viral infections.
Purpose of the Study:
- To review the structural and functional characteristics of SARS-CoV-2 3-chymotrypsin-like protease (3CLpro).
- To highlight advancements in the development of 3CLpro inhibitors as antiviral treatments for COVID-19.
- To provide a comprehensive resource on 3CLpro's role in the viral life cycle and therapeutic targeting.
Main Methods:
- Literature review of studies on SARS-CoV-2 3CLpro structure and function.
- Analysis of various inhibitor screening strategies, including peptide-like and small molecule approaches.
- Examination of both active site and allosteric inhibition mechanisms against 3CLpro.
Main Results:
- 3CLpro is a critical cysteine protease essential for SARS-CoV-2 replication.
- Inhibitors targeting 3CLpro's active or allosteric sites effectively impede viral polyprotein processing.
- Multiple 3CLpro inhibitors have been identified, with some already approved for clinical use.
Conclusions:
- 3CLpro is a validated and vital target for antiviral drug development against SARS-CoV-2.
- Targeting 3CLpro offers a promising strategy for managing COVID-19.
- Continued research into 3CLpro inhibitors is essential for combating current and future coronavirus threats.
Related Concept Videos
02:28Leaky Scanning
5.1K
During most eukaryotic translation processes, the small 40S ribosome subunit scans an mRNA from its 5' end until it encounters the first start AUG codon. The large 60S ribosomal subunit then joins the smaller one to initiate protein synthesis. The location of the translation initiation is largely determined by the nucleotides near the start codon as there may be multiple translation initiation sites present on the mRNA. Marilyn Kozak discovered that the sequence RCCAUGG (where R...
5.1K
02:50Conjugated Proteins
18.3K
Simple proteins and protein complexes contain only amino acids. In contrast, many other proteins, called conjugated proteins, covalently bond with non-protein moieties.
Nucleoproteins are protein complexes that contain nucleic acids, categorized as deoxyribonucleoproteins (DNPs) or ribonucleoproteins (RNPs) respectively. The nucleosome is a typical example of a DNP where nuclear DNA is associated with histone proteins. The major antigen for the Covid-19 virus SARS-CoV is an RNP that is critical...
Nucleoproteins are protein complexes that contain nucleic acids, categorized as deoxyribonucleoproteins (DNPs) or ribonucleoproteins (RNPs) respectively. The nucleosome is a typical example of a DNP where nuclear DNA is associated with histone proteins. The major antigen for the Covid-19 virus SARS-CoV is an RNP that is critical...
18.3K